Clinical Trials Logo

Clinical Trial Summary

1. Evaluation of fractional Co2 laser as a treatment option for wide pores in skin type (III - VI) 2. Evaluation of mesobotox as a new modality for improving wide pores appearance. 3. Comparison of both treatment modalities in treatment of enlarged pores.


Clinical Trial Description

Skin pores (SP), as they are called by laymen, are common and benign features mostly located on the face (nose, cheeks, etc) that generate many aesthetic concerns or complaints. Enlarged skin pores refer to conditions that present with visible topographic changes of skin surfaces. Although not a medical concern, enlarged pores are a cosmetic concern for a large number of individuals. Enlarged facial pores affect individuals of different ages, sexes, and races for which many seek treatment. The exact patho-mechanism of enlarged facial pores is not completely understood. Possible causes include genetic predisposition, seborrhea, aging, increased ultraviolet exposure and comedogenic products. The treatment of dilated facial pores is difficult, and the ideal modality is not established yet. Many treatment modalities reduce facial pores' count and area, including oral and topical medications as well as different wavelengths of laser. Different ablative and non ablative lasers have been used in the treatment of dilated pores with variable outcomes. The short-term results showed that treatment with low energy level CO2 fractional laser therapy could be a safe and effective option for patients with Fitzpatrick skin Types III and IV who are concerned with enlarged pores. Microbotox also called mesobotox, is the injection of multiple microdroplets of diluted onabotulinum toxin A into the upper dermis. It has been previously used in study to decrease pore size and to improve skin texture. Microbotox has been proved to be effective in improving the sheen and texture of the skin, as well as decreasing sweat and sebum production and enlarged pores as it causes atrophy of sebaceous glands, which subsequently causes tightening of the skin envelope. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05923996
Study type Interventional
Source Assiut University
Contact Ahmed AE Ibrahim
Phone 01200889665
Email ahmedalaa12494@gmail.com
Status Not yet recruiting
Phase Phase 1
Start date February 1, 2024
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04539886 - Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions N/A
Completed NCT01407770 - Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed NCT05619471 - VIO Imaging for Skin Tissue Assessment (VISTA) N/A
Not yet recruiting NCT05554523 - How Does Skin Tone Affect Quantitative Photoacoustic Imaging
Completed NCT04872946 - Topical and Oral Regimen for Skin Health N/A
Completed NCT04449159 - Efficacy of Vinh Wellness Collagen on Skin Health N/A
Completed NCT03002194 - Change in Skin Elasticity With RF and PEMF N/A
Enrolling by invitation NCT04934254 - THE NEWBORN SKIN ASSESSMENT ATTITUDE SCALE
Completed NCT05410964 - Non-Linear Imaging of Skin In Vivo
Completed NCT03612570 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia N/A
Withdrawn NCT03862872 - Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers N/A
Terminated NCT04253418 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study N/A
Recruiting NCT04525521 - Hand Sanitizer Effects on the Skin Barrier
Withdrawn NCT01801878 - Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts N/A
Completed NCT00839280 - Moisturizing Effect of Two Dexpanthenol Formulations Phase 2
Completed NCT00520910 - Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers Phase 2
Completed NCT04813887 - Skin Diseases and Pregnancy: Which Heathcare Professionals ?
Recruiting NCT05641168 - A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal Skin N/A
Terminated NCT01108523 - Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage Phase 0
Completed NCT05319847 - An Exploratory Investigation of a Male Focused Skincare Supplement N/A